I DISCOVER I LIMITED
Company number 14502519 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
I DISCOVER I LIMITED - Analysis Report
Company Number: 14502519
Analysis Date: 2025-07-29 12:48 UTC
Financial Health Assessment of I DISCOVER I LIMITED
1. Financial Health Score: D
Explanation:
The company shows significant signs of financial distress with negative net assets and net current liabilities surpassing its current assets. Although it is a micro-entity in its early stage (incorporated in late 2022), the financial "vital signs" suggest an imbalance that requires urgent attention. The score reflects a precarious financial condition, bordering on insolvency risk without corrective measures.
2. Key Vital Signs
| Metric | Value (£) | Interpretation |
|---|---|---|
| Current Assets | 1 | Extremely low cash or liquid assets — "barely any healthy blood flow" in terms of cash resources. |
| Current Liabilities | 479 | Debts due within one year significantly higher than current assets — "obstruction in cash flow." |
| Net Current Assets (Working Capital) | -478 | Negative working capital indicates short-term liquidity issues — "symptom of distress." |
| Net Assets (Total Equity) | -478 | Negative net worth implies liabilities exceed assets — "critical warning sign." |
| Shareholders' Funds | -478 | Equity capital is in deficit, indicating accumulated losses or undercapitalization. |
| Average Number of Employees | 1 | Very small operation, which aligns with micro-entity status but limits economies of scale. |
| Going Concern Statement | Yes | Director support is currently sustaining operations — "life support" to the company's existence. |
3. Diagnosis
I DISCOVER I LIMITED is in the very early stage of its business life cycle but already exhibits financial symptoms akin to a patient with severe nutrient deficiency:
Liquidity Crisis: The company has only £1 in current assets against £479 of short-term liabilities, indicating it does not have sufficient liquid resources to cover immediate obligations. This is a classic "cash flow blockage" scenario that can threaten solvency if unresolved.
Negative Equity: The negative net assets position signals that total liabilities outweigh the company's resources, which is alarming even for a startup. This "balance sheet anemia" could restrict the company’s ability to raise external finance or trade credit.
Dependency on Director Support: The going concern statement reveals the company’s survival depends on the director’s ongoing financial backing. Without this "lifeline," the company risks failing to meet its obligations.
Micro-Entity Status & Early Stage: The company benefits from simplified reporting and is likely in the investment or development phase, which may explain current losses or low asset base. However, prolonged negative equity and poor liquidity must be reversed to avoid insolvency risks.
4. Recommendations
Immediate Actions:
Inject Capital or Obtain Funding: The director (currently the sole shareholder) should consider injecting fresh equity or arranging short-term financing to restore positive working capital and strengthen the balance sheet.
Improve Cash Flow Management: Monitor and forecast cash flows rigorously. Prioritize timely collection of receivables and negotiate longer payment terms with creditors to ease liquidity pressure.
Cost Control and Revenue Growth: Given the early stage, focus on scaling revenue quickly while controlling expenses tightly. Explore additional sales channels or services in the educational support sector to boost turnover.
Regular Financial Monitoring: Implement monthly financial reviews to detect early symptoms of distress and adjust operations accordingly.
Plan for Sustainability: Develop a medium-term business plan addressing profitability and capital structure to transition from dependency on director support to self-sustainability.
Medical Analogy Summary
The company is currently like a patient admitted with severe dehydration and malnutrition (negative net assets and poor liquidity). The director’s ongoing support acts as intravenous fluids keeping it alive, but without nutritional rehabilitation (capital injection and improved cash flow), the prognosis is poor. Early intervention is critical to restore financial health and avoid the risk of "financial collapse."
Sign in to generate a free AI analysis of this company — no password needed, just an email link.